Mar 19, 2019 / 08:30PM GMT
Operator
Greetings, and welcome to the Interpace Diagnostics Group Fourth Quarter and Full Year 2018 Financial Results, Business Progress and Recent Announcements Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I'd like to turn the conference over to your host, Jack Stover, CEO. Thank you, you may begin.
Jack E. Stover - Interpace Diagnostics Group, Inc. - CEO, President and Director
Thank you, Matt, and good afternoon, and thank you for joining us today for a review of our fourth quarter and fiscal year ended December 31, 2018 as well as activities to date.
With me today is Jim Early, our Chief Financial Officer. After my overview, Jim will review our financial performance with you in more detail. Following that, we will open the call for your questions.
Let me remind you of our mission here at Interpace as I do on all calls. We are a fully integrated commercial and bioinformatics company that provides molecular and related first-line diagnostic tests and pathology services by leveraging the latest
Q4 2018 Interpace Diagnostics Group Inc Earnings Call Transcript
Mar 20, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers